DECISION OF THE EEA JOINT COMMITTEE No 122/2024

of 12 June 2024

amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2024/2447]

THE EEA JOINT COMMITTEE,

Having regard to the Agreement on the European Economic Area (“the EEA Agreement”), and in particular Article 98 thereof,

Whereas:

(1) Commission Implementing Regulation (EU) 2023/2713 of 5 December 2023 designating European Union reference laboratories in the field of in vitro diagnostic medical devices ( 1 ) is to be incorporated into the EEA Agreement.

(2) Annex II to the EEA Agreement should therefore be amended accordingly,

HAS ADOPTED THIS DECISION:

Article 1

The following point is inserted after point 12c (Commission Implementing Regulation (EU) 2022/945) of Chapter XXX of Annex II to the EEA Agreement:

‘12d.

32023 R 2713 : Commission Implementing Regulation (EU) 2023/2713 of 5 December 2023 designating European Union reference laboratories in the field of in vitro diagnostic medical devices ( OJ L, 2023/2713, 6.12.2023 ).’

Article 2

The text of Implementing Regulation (EU) 2023/2713 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union , shall be authentic.

Article 3

This Decision shall enter into force on 13 June 2024, provided that all the notifications under Article 103(1) of the EEA Agreement have been made ( *1 ) .

Article 4

This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union .

Done at Brussels, 12 June 2024.

For the EEA Joint Committee

The President

Nicolas VON LINGEN

( 1 ) OJ L, 2023/2713, 6.12.2023 .

( *1 ) No constitutional requirements indicated.

ELI: http://data.europa.eu/eli/dec/2024/2447/oj

ISSN 1977-0677 (electronic edition)